Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Bionor Pharma ASA - Mandatory notification of trade

Bionor Pharma ASA
Posted on: 19 Sep 16

Bionor Pharma ASA - Mandatory notification of trade - Lars H Høie



Reference is made to the announcement by Bionor Pharma ASA on 14 December 2016 regarding completion of EGM.

Upon issuance of the Consideration Shares, the shares in the Private Placement and the shares in the Subsequent Offering, Lars H. Høie will hold 128,973,522 shares and votes in the Company, corresponding to 1.33% of the total share capital and votes of the Company.

This information is subject to the disclosure requirements set out in section 4-3 of the Norwegian Securities Trading Act.


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Bionor Pharma ASA via GlobeNewswire

Last updated on: 16/12/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.